Suppressive Effects of Ginsenoside Rh1 on HMGB1-Mediated Septic Responses

Immunology and Microbiology

• Mouse 100%
• Mouse Model 100%
• Survival Rate 100%
• Umbilical Vein Endothelial Cell 100%
• Leukocyte Migration 100%
• Inflammation Response 50%
• Ginseng 50%
• Mediator 50%
• Tumor Necrosis Factor Alpha 50%
• Complement Factor B 50%
• Interleukin 6 50%
• Biological Activity 50%
• Leukocyte Adherence 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Sepsis 100%
• Mouse 33%
• Survival Rate 33%
• Mouse Model 33%
• Inflammation 16%
• Antioxidant 16%
• Ginseng 16%
• Antiinfective Agent 16%
• Anti-Inflammatory Drug 16%
• Interleukin 6 16%
• Tumor Necrosis Factor 16%
• Lipopolysaccharide 16%
• Biological Activity 16%
• Alternative Complement Pathway C3 C5 Convertase 16%
• Nuclear Factor 16%
• Mitogen Activated Protein Kinase 3 16%
• Tissue Injury 16%

Medicine and Dentistry

• Ginsenoside 100%
• Sepsis 50%
• Therapeutic Procedure 16%
• Survival Rate 16%
• Human Umbilical Vein Endothelial Cell 16%
• Leukocyte Migration 16%
• Antiinfective Agent 8%
• Antioxidant 8%
• Anti-Inflammatory Drug 8%
• Serositis 8%
• Tumor Necrosis Factor 8%
• Mitogen Activated Protein Kinase 3 8%
• Biological Activity 8%
• Ginseng 8%
• Lipopolysaccharide 8%
• Nuclear Factor 8%
• Alternative Complement Pathway C3 C5 Convertase 8%
• Mediator 8%
• Interleukin 6 8%
• Puncture 8%
• Ligation 8%
• Tissue Injury 8%